01.12.2002 | Original Article
Therapeutic advantage from combining paclitaxel with the hypoxia-selective cytotoxin NLCQ-1 in murine tumor- or human xenograft-bearing mice
Erschienen in: Cancer Chemotherapy and Pharmacology | Ausgabe 6/2002
Einloggen, um Zugang zu erhalten